SINGAPORE (Feb 26): Consumer healthcare company Cordlife Group is partnering US-based PlumCare to offer a genetic testing service to help families in Asia identify gene variants associated with increased risk of developing inherited conditions such as breast and ovarian cancer.

Cordlife will launch and market the test under its Genscreen brand.

Known as PlumCare DNA Advisor, the test requires participation from at least three family members to enable better counselling and insights.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook